Researchers have identified a key weakness in acute myeloid leukaemia, offering a promising new strategy to delay the ...

A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...

A three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...

This course provides practical and theoretical education for the support of a modern radiotherapy physics service within radiotherapy. It is aimed primarily at recently qualified radiotherapy ...

Help women with ovarian and breast cancer live longer and better lives by supporting the Institute of Cancer Research. Donate ...

Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

Cancer Research UK (CRUK) has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics ...

Professor Vlad Pena's group focuses on the structural basis of human pre-mRNA processing under normal, pathological and drug-induced conditions. Imogen is a PhD student in the Division of Structural ...

Professor Pascal Meier and his group are investigating the complex relationship between cell death, immunity and tumorigenesis. Particularly, they are focussing on the role of cell death and ...